We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

ERBA MANNHEIM

Erba Mannheim is an IVD solutions provider focused on improving health outcomes in developing nations. Originally fou... read more Featured Products: More products

Download Mobile App





Erba Introduces XL Range of Fully Automated Clinical Chemistry Systems at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 08 Feb 2023

Erba Mannheim (London, UK) is introducing its latest XL range of fully automated clinical chemistry systems at the 22nd edition of Medlab Middle East Congress taking place live, in-person from 6-9 February 2023. More...

At Medlab Middle East 2023, Erba is showcasing the XL range of four fully automated clinical chemistry systems that incorporate state-of-the-art features. These rugged and performance-oriented systems boost lab productivity and throughput, making them an essential part of any start-up, medium or advanced lab. They support a wide test menu spanning routine clinical chemistry, electrolytes, immunoassays and coagulation tests. The XL range includes the XL 1000 fully automated clinical chemistry analyzer that guarantees high resolution measurement with automatic sample conveyor for comfortable workflow in laboratories with high sample throughput. It also includes the XL 200 fully automated random access clinical chemistry analyzer having a throughput of 200 tests/hr (photometric test) and 400 tests/hr with ISE (Na/K/Cl/Li). Also part of the XL range is the XL 640 fully automated biochemistry analyzer with a throughput of 640 tests per hour that is powerful and robust enough to keep up with the heavy demands of everyday testing, as well as the XL 180 that is designed to give convenience and flexibility in operation and good quality reporting for small and medium-sized laboratories.

From its hematology line, Erba is highlighting the H360 automated 3-part differential hematology analyzer that can be used as a complete blood count analyzer by small laboratories or as a second instrument. Within its coagulation line, Erba is showcasing the ECL 105 single channel semi-automated system for small laboratories that performs measurements of all clotting assays as well as DDimer. With a color touch-screen and intuitive user interface, the ECL-105 is simple to use and ensures quality results. Also featuring at the show is the LAURA Smart urine strip reader which is an efficient and compact solution for routine chemical urinalysis. The equipment's semi-automatic technology facilitates the sample process, contributing to the correct diagnosis of patients. In addition, Erba is presenting the EC90 electrolyte analyzer featuring clean biosensor and maintenance-free technology. Designed for easy use, efficient operation and reliability, the EC90 has an analysis time of only 35 seconds.

Related Links:
Erba Mannheim 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: LVOne uses blood-based biomarkers to detect stroke and identify large vessel occlusion before hospital arrival, providing objective results earlier than traditional assessments. (Photo courtesy of UpFront Diagnostics)

First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

Rapid stroke identification before hospital arrival is critical because treatment efficacy declines with every minute of delay. However, definitive assessment typically requires hospital-based imaging,... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Mpox Analysis Reveals Substantial Suspected False Positives Associated with Contamination

Reliable confirmation of mpox can be difficult where multiple rash-causing illnesses co-circulate and laboratory capacity is limited. Although PCR is central to case detection, contamination during specimen... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Ebola remains a rapidly evolving public health threat with high mortality, underscoring the need for timely diagnosis and decentralized testing closer to patients (Image Credit: Adobe Stock)

Collaboration Targets Blood-Based Ebola Detection Outside Central Laboratories

Co-Diagnostics, Inc. (Salt Lake City, UT, USA) and ReadyGo Diagnostics Ltd. (Bath, UK) have initiated a collaboration to evaluate ReadyGo’s GoCollect with the Co-Dx PCR platform for blood-based molecular... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.